HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Improved outcome of patients with diabetes mellitus with good glycemic control in the cardiac intensive care unit: a retrospective study.

AbstractBACKGROUND:
Diabetes mellitus (DM) is a prevalent metabolic disease characterized by chronic hyperglycemia. A primary burden of DM is related to its long-term complications, which have been shown to impact the course of hospitalization and to influence patients' outcome.
AIM:
To assess the role of in-hospital glucose control on length of stay, 30-days and 1-year mortality.
METHODS:
This is a retrospective study that included patients admitted to the cardiac intensive care unit (CICU) of the Edith Wolfson Medical Centre between 01 January, 2010 and 31 December 2013. Blood glucose was measured by glucometer and fed into an interactive database. Glucose status was referred to as controlled when more than 50% of a given patients glucose values were between 71 and 200 mg/dL. Chisquared tests were used to assess the distribution of categorical variables, while the ttest was applied for continuous variables. A multivariate logistic regression model was used to analyze the association between glucose control and mortality. Cox regression was conducted to assess survival and 1-year mortality.
RESULTS:
2466 patients were admitted to the CICU over the study period, of which 370 had concomitant diabetes mellitus. Controlled glucose status was associated with shorter length of hospital stay (1.6 ± 1.7 versus 2.6 ± 3.0, p < 0.001), reduced 30-day mortality (0.7% versus 4.6%, p < 0.001), and improved 1-year mortality (2.2% versus 7.5%, p < 0.001). Moreover, attainment of glucose control was independently associated with a significant decrease in 1-year mortality (OR = 0.371, 95% CI 0.140-0.988, p = 0.047).
CONCLUSION:
In-hospital control of glucose parameters is associated with shorter length of hospital stay, and lowered 30-day and 1-year mortality. An effort to maintain glucose levels within reference ranges is warranted in critically ill patients to reduce mortality.
AuthorsKassem Sharif, Suheil Ghadir, Daniela Jakubowicz, Howard Amital, Nicola Luigi Bragazzi, Abdulla Watad, Julio Wainstein, Yosefa Bar-Dayan
JournalCardiovascular diabetology (Cardiovasc Diabetol) Vol. 18 Issue 1 Pg. 4 (01 11 2019) ISSN: 1475-2840 [Electronic] England
PMID30634972 (Publication Type: Journal Article)
Chemical References
  • Biomarkers
  • Blood Glucose
Topics
  • Aged
  • Biomarkers (blood)
  • Blood Glucose (drug effects, metabolism)
  • Coronary Care Units
  • Critical Illness
  • Databases, Factual
  • Diabetes Mellitus (blood, diagnosis, drug therapy, mortality)
  • Female
  • Heart Diseases (diagnosis, mortality, therapy)
  • Humans
  • Intensive Care Units
  • Length of Stay
  • Male
  • Middle Aged
  • Patient Admission
  • Retrospective Studies
  • Risk Factors
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: